The metabolic clock of ketamine abuse in rats by a machine learning model.

Journal: Scientific reports
PMID:

Abstract

Ketamine has recently become an anesthetic drug used in human and veterinary clinical medicine for illicit abuse worldwide, but the detection of illicit abuse and inference of time intervals following ketamine abuse are challenging issues in forensic toxicological investigations. Here, we developed methods to estimate time intervals since ketamine use is based on significant metabolite changes in rat serum over time after a single intraperitoneal injection of ketamine, and global metabolomics was quantified by ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry (UPLC-Q-TOF-MS). Thirty-five rats were treated with saline (control) or ketamine at 3 doses (30, 60, and 90 mg/kg), and the serum was collected at 21 time points (0 h to 29 d). Time-dependent rather than dose-dependent features were observed. Thirty-nine potential biomarkers were identified, including ketamine and its metabolites, lipids, serotonin and other molecules, which were used for building a random forest model to estimate time intervals up to 29 days after ketamine treatment. The accuracy of the model was 85.37% in the cross-validation set and 58.33% in the validation set. This study provides further understanding of the time-dependent changes in metabolites induced by ketamine abuse.

Authors

  • Tao Wang
    Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Qian Zheng
    State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Department of Oral and Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
  • Qian Yang
    Center for Advanced Scientific Instrumentation, University of Wyoming, Laramie, WY, United States.
  • Fang Guo
  • Haiyan Cui
    School of Forensic Medicine, Shanxi Medical University, Jinzhong, 030600, Shanxi, China.
  • Meng Hu
    Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
  • Chao Zhang
    School of Information Engineering, Suqian University, Suqian, Jiangsu, China.
  • Zhe Chen
    Evidence-based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Shanlin Fu
    Centre for Forensic Science, University of Technology Sydney, Ultimo, New South Wales, Australia.
  • Zhongyuan Guo
    School of Electronic Information, Wuhan University, Wuhan 430072, China.
  • Zhiwen Wei
    School of Forensic Medicine, Shanxi Medical University, Jinzhong, 030600, Shanxi, China. weizhiwen2000@163.com.
  • Keming Yun
    School of Forensic Medicine, Shanxi Medical University, Jinzhong, 030600, Shanxi, China. yunkeming5142@163.com.